Peter M. Strumph
Directeur/Bestuurslid bij Amygdala Neurosciences, Inc.
Actieve functies van Peter M. Strumph
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Amygdala Neurosciences, Inc.
Amygdala Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Amygdala Neurosciences, Inc. is a biopharmaceutical company. The firm focuses on improving public health by developing and commercializing therapy to treat substance use disorders. Its development programs include treatment and prevention of opioid, nicotine, alcohol and cocaine use disorders. The company was founded by Lou Lange, Ivan Diamond, Peter Strumph, Brent Blackburn, and Adrienne MacMillan in 2015 and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | 01-01-2016 | - |
Algemeen Directeur | 01-01-2015 | - | |
Oprichter | 01-01-2015 | - | |
President | 01-01-2015 | - |
Loopbaan van Peter M. Strumph
Eerdere bekende functies van Peter M. Strumph
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CODEXIS, INC. | Algemeen Directeur | 20-02-2012 | 22-02-2012 |
Corporate Officer/Principal | 29-06-2010 | 20-02-2012 | |
President | 28-06-2010 | 13-06-2012 | |
CAPRICOR THERAPEUTICS, INC. | President | 01-09-2007 | 10-06-2009 |
Nile Therapeutics, Inc. /Old/ | President | 17-06-1996 | 11-10-2007 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Operationeel Directeur | 01-01-1997 | 01-01-2007 |
PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-04-2013 | - |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Opleiding van Peter M. Strumph
The Wharton School of the University of Pennsylvania | Masters Business Admin |
University of Pennsylvania | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 10 |
Operationeel
President | 4 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Sectoraal
Health Technology | 7 |
Consumer Services | 3 |
Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
CAPRICOR THERAPEUTICS, INC. | Health Technology |
CODEXIS, INC. | Process Industries |
Bedrijven in privébezit | 5 |
---|---|
Nile Therapeutics, Inc. /Old/ | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Amygdala Neurosciences, Inc.
Amygdala Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Amygdala Neurosciences, Inc. is a biopharmaceutical company. The firm focuses on improving public health by developing and commercializing therapy to treat substance use disorders. Its development programs include treatment and prevention of opioid, nicotine, alcohol and cocaine use disorders. The company was founded by Lou Lange, Ivan Diamond, Peter Strumph, Brent Blackburn, and Adrienne MacMillan in 2015 and is headquartered in San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Peter M. Strumph
- Ervaring